Freestone Capital Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-36
Closed -$4.09K 1321
2020
Q3
$4.09K Buy
+36
New +$3.78K ﹤0.01% 918

Other funds holding TNDM

Freestone Capital Holdings's TNDM Position: Q4 2020 in Review

Freestone Capital Holdings sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 36 shares — an estimated $4.09K sold.

Freestone Capital Holdings first reported a position in TNDM in Q3 2020 and held it in 1 quarter. The position peaked at $4.09K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • Freestone Capital Holdings reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • Freestone Capital Holdings sold 36 Tandem Diabetes Care shares in Q4 2020, an estimated $4.09K.
  • Freestone Capital Holdings first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 1 quarter.
  • Freestone Capital Holdings's Tandem Diabetes Care position peaked at $4.09K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on Freestone Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.